Wallcur to Provide Custom Practice Medication Packages for Elsevier's SimChart®
PHILADELPHIA, June 26, 2014 /PRNewswire/ --
Wallcur's Practi-Pack pre-built practice medication packages to complement Elsevier's simulated electronic health record learning tool for nursing students
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that Wallcur, a provider of practice medications for clinical simulation and health education, will make custom practice medications available to Elsevier's SimChart customers.
Nursing schools using Elsevier's SimChart, an educational electronic health record (EHR), have access to multiple hands-on, evidence-based practice scenarios that include preparing and administering of medications to patients. Through Elsevier's relationship with Wallcur, SimChart customers now have the ability to purchase Practi-Packs, pre-built packages of medications that match up with 10 SimChart simulated cases.
"Hands-on experience in a clinical setting is key for the advancement of health science students, and practice with proper medication administration is an important part of that education," said John Danaher, President, Education, Elsevier. "Providing students with realistic practice medications allows them to learn in a safe environment and encourages preparedness for the clinical setting."
The Practi-Packs have bar codes, enabling students to verify drug type and dosage when administering the practice medication. The medication information also populates the EHR. The simulation cases provide a realistic look and feel of a clinical setting and allow students to treat different patient ailments with the Practi-Packs.
"Our mission at Wallcur is to provide products that simulate clinical learning in a safe, non-clinical environment," said Wendy LaGrange, Director of Sales & Marketing, Wallcur. "By partnering with Elsevier, we're able to make true-to-life medications available to health science students as they prepare for the challenges of tomorrow's healthcare system."
A sample simulation case includes a patient with myocardial infarction who is experiencing hypertension and chest pain. After assessing the simulated patient's symptoms, the student will use the pre-packaged Practi-Packs to properly care for the patient. Each Practi-Pack will have either two or four sets of the needed medications so students can run through the scenario several times to encourage an increased level of comfort with the medication administration and scenario results.
For more information, go to http://www.elsevieradvantage.com.
For over 40 years, Wallcur has been the leading innovator and provider of educational training and simulation products for nursing, medical assistance, pharmaceutical, EMS/paramedic, medical corps and other allied health programs throughout the world. Our Practi-Products™ are designed to provide safe, accurate and realistic clinical simulation practices guaranteed to increase student readiness, as well as cut down on medication and administration errors. Our Practi™ brand guarantees the highest quality, true-to-life realistic designs to create a safe and authentic practice that is easily integrated into any new or existing curriculum, with the best customer service and availability in the industry.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey - and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Corporate Relations